Want more information? Let us know what you need and we will get back to you. We look forward to hearing from you!
Verity Solutions is both a pioneer and a leader in 340B split billing software solutions – our robust feature-set is flexible to meet and exceed the complex demands of our customers.
Verity 340B® Contract Pharmacy solutions allow health systems to capture additional 340B savings from Covered Entity scripts dispensed at retail pharmacies.
Verity Solutions has developed an innovative Specialty Contract Pharmacy model that allows covered entities to optimize their 340B savings by partnering with market-leading specialty, hemophilia, and home infusion pharmacies.
Rely on Verity Solutions to proactively foster audit compliance including program set-up, administration, legal and governmental affairs. Let our compliance team and our impeccable HRSA audit track record work for you.
With 340B prices changing every quarter, Verity 340B® Purchase Analytics is an automated solution to help Covered Entities capture additional savings opportunities by identifying the lowest spread between 340B and non-340B drug prices, providing the “best fit” within your inventory. Verity 340B® Purchase Analytics enhances any existing 340B program, regardless of which Third Party Administrator you use.
Health Systems nationwide struggle to manage 340B program compliance due to evolving and expanding regulations and lack of staff or expertise. Consequences of non-compliance range from monetary penalties to the devastating possibility of Program ineligibility. Verity 340B® web-based Compliance Manager stores your 340B program documentation and provides tools for you to fulfill your self-audit requirements quickly and easily.
“Verity Solutions aims to find whatever solution or application may be needed. This often requires one-off programming to make the software work. That has been the real strength of Verity Solutions. That flexibility has given them a chance to grow in a lot of unexpected directions, and their competitors are trying to catch up.”— VP/OTHER EXECUTIVE